Dawn Carter Bir, Chief Commercial Officer at REATA PHARMACEUTICALS INC (RETA), sold 18,634 shares at $86.77 ($1.6M) on 2023-03-13, disclosed to the SEC on 2023-03-15.
Open-market sale of $1.6M RETA by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.77 | 9,317 | $808K | 50.0% |
| 2 | $86.77 | 9,317 | $808K | 50.0% |
| Total | $86.77 avg | 18,634 | $1.6M | 100% |
| Filing → |
| RETA | SELL | 2023-05-17 | $186K | — | Filing → |
| RETA | SELL | 2023-03-08 | $17.0M | — | Filing → |
| RETA | SELL | 2023-03-06 | $382K | — | Filing → |